Brain implant delivers ultrasonic waves to brain treating cancer, Alzheimer’s

A recent study published in Advanced Healthcare Materials outlines a new ceramic skull implant capable of delivering ultrasound treatments.

Ultrasonic waves can treat many types of brain diseases like Alzheimer’s and Parkinson’s. They can also be used to combat brain cancer and dissolve blood clots following stroke. These waves, while showing such potential, remain unable to pass through the two to eight mm thick skull wall.

Led by Guillermo Aguilar, professor and chair of mechanical engineering in University of California, Riverside's Bourns College of Engineering, and Javier E. Garay, professor of mechanical and aerospace engineering in UC San Diego's Jacobs School of Engineering, the team developed a ceramic implant that allows for ultrasound to pass into the brain. The biocompatible and shatter-proof material makes the implant viable and safe for implantation. In testing, physicians were able to deliver therapeutic sound waves to the brain both on demand and in a routine.

"These materials are already being used in dental crowns and hip replacements, and our team is working to extend their application to the diagnosis and treatment of a wide variety of brain pathologies and neurological disorders," Aguilar said. "Developing an optically and radio-frequency transparent cranial implant was already an exciting accomplishment, and we continue to work to make this implant a reality. Now, proving that ultrasound could be transmitted through the implant could expand its therapeutic capabilities even further."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”